GeneOne Life Science, Inc. (KRX:011000)
South Korea flag South Korea · Delayed Price · Currency is KRW
2,730.00
-285.00 (-9.45%)
Last updated: Jun 5, 2025

GeneOne Life Science Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Net Income
-47,893-48,537-77,768-38,150-15,888-18,648
Upgrade
Depreciation & Amortization
18,15217,96112,7765,4244,6504,021
Upgrade
Loss (Gain) From Sale of Assets
-2.82-2.82-3.4-1.31106.64-
Upgrade
Asset Writedown & Restructuring Costs
--32,309---
Upgrade
Loss (Gain) From Sale of Investments
3.664.25----
Upgrade
Provision & Write-off of Bad Debts
-84.112.7-845.521,293111.17-174.13
Upgrade
Other Operating Activities
9,2208,4423,1713,579-2,0841,219
Upgrade
Change in Accounts Receivable
-2,621407.864,835-2,84868.061,672
Upgrade
Change in Inventory
-1,075-2,096-207.63-4,256-2,415409.55
Upgrade
Change in Accounts Payable
7,29110,2403,801-10,00310,6104,529
Upgrade
Change in Income Taxes
2.15----97.74-67.04
Upgrade
Change in Other Net Operating Assets
4,323-1,987188.3320,850-194.83-8,908
Upgrade
Operating Cash Flow
-13,176-16,058-21,744-24,113-4,849-15,916
Upgrade
Capital Expenditures
-3,263-3,298-5,601-45,306-82,442-16,153
Upgrade
Sale of Property, Plant & Equipment
2.122.1215.7-29.13-
Upgrade
Sale (Purchase) of Intangibles
-99.95-69.14-51.59-101.81-75.24-216.6
Upgrade
Investment in Securities
172.08470.7931,52953,000-57,000-27,536
Upgrade
Other Investing Activities
48046-0-151.33-5,961-
Upgrade
Investing Cash Flow
-2,706-2,84525,8928,055-146,398-44,305
Upgrade
Short-Term Debt Issued
-1,3523,792701.151,054-
Upgrade
Long-Term Debt Issued
-9,2246,27111,469-23,520
Upgrade
Total Debt Issued
12,47210,57610,06312,1711,05423,520
Upgrade
Short-Term Debt Repaid
--506.85-2,100--150.86-958.08
Upgrade
Long-Term Debt Repaid
--2,700-18,712-5,537-1,639-10,731
Upgrade
Total Debt Repaid
-3,103-3,207-20,812-5,537-1,790-11,689
Upgrade
Net Debt Issued (Repaid)
9,3707,369-10,7496,633-735.3511,831
Upgrade
Issuance of Common Stock
-3,5902,470382.44112,60994,404
Upgrade
Other Financing Activities
-0-0-5.64-2.97-849.86-
Upgrade
Financing Cash Flow
9,37010,959-8,2857,013111,023106,235
Upgrade
Foreign Exchange Rate Adjustments
1113.81-13.29-3.42101.37-503.35
Upgrade
Miscellaneous Cash Flow Adjustments
00-000
Upgrade
Net Cash Flow
-6,502-7,931-4,150-9,049-40,12245,510
Upgrade
Free Cash Flow
-16,439-19,356-27,345-69,419-87,291-32,069
Upgrade
Free Cash Flow Margin
-44.20%-54.19%-68.02%-142.49%-225.56%-77.27%
Upgrade
Free Cash Flow Per Share
-206.08-243.60-351.70-895.90-1175.77-531.20
Upgrade
Cash Interest Paid
65.7874.6682.1558.5-48.96
Upgrade
Cash Income Tax Paid
--236.05104.9326.55189.71-
Upgrade
Levered Free Cash Flow
7,8632,211-22,581-73,691-103,116-13,891
Upgrade
Unlevered Free Cash Flow
9,5433,558-21,843-69,123-100,332-13,498
Upgrade
Change in Net Working Capital
-20,382-15,863-1,2634,0145,259-10,432
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.